Late entry into HIV care: Estimated impact on AIDS mortality rates in Brazil, 2003-2006

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Grangeiro, Alexandre ^a   Escuder, Maria Mercedes ^b   Menezes, Paulo Rossi ^a   Alencar, Rosa ^b   de Castilho, Euclides Ayres ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Secretaria de Estado da Saude de Sao Paulo   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; HEALTH CARE ACCESS; HUMAN; INFORMATION SYSTEM; MAJOR CLINICAL STUDY; MORTALITY; PUBLIC HEALTH SERVICE; THERAPY DELAY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREVALENCE; SURVIVAL RATE; TIME; WORLD HEALTH ORGANIZATION;

ANTIVIRUS AGENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; BRAZIL; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; PREVALENCE; SURVIVAL RATE; TIME FACTORS; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 79551537508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014585     Document Type: Article

References (47)

1. World Health Organization, Joint United Nations Programme on HIV/AIDS, United Nations Children' s Fund (2009) Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. Geneva: World Health Organization. Available: http://www.who.int/hiv/pub/tuapr_2009_en.pdf. Accessed 2010 June 8.
2. Granich R, Gilks C, Dye C, Cock K, Williams B (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
3. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, et al. (2010) Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet (on line) doi:10.1016/So140-6736(10) 60705-2.
4. Attia S, Egger M, Müller M, Zwahlen M, Low N (2009) Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 23. doi:10.1097/QAD.0b013e32832b7dca.
5. Brinkhof MWG, Boulle A, Weigel R, Messou E, Mathers C, et al. (2009) Mortality of HIV-infected patients starting antiretroviral therapy in Sub- Saharan Africa. Comparison with HIV-unrelated mortality. PLoS Med 6(4): e1000066.
6. Egger M, May M, Chêne G, Phllips AN, Ledergerber B, et al. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360: 119-129.
7. Chasombat S, McConnell MS, Sinagphoe U, Yaktanont P, MPharm TJ, et al. (2009) National expansion of retroviral treatment in Thailand, 2000-2007: Program scale-up and patient outcomes. J Acquir Immune Defic Syndr 50: 506-512.
8. Zhang F, Zhihui D, Ma Y, Zhao Y, Liu Z, et al. (2009) Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med 151: 241-251.
9. Lawn SD, Little F, Bekker L, Kaplan R, Campbel E, et al. (2009) Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South African. AIDS 23: 335-342.
10. Tuboi SH, Schechter M, McGowan CC, Cesar C, Krolewiecki A, et al. (2009) Mortality during the first year potent antiretroviral therapy in HIV-1 infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr 51: 615-623.
11. Krentz HB, Auld MC, Gill MJ (2004) The high cost medical care for patients who present late (CD4,200 cell/L) with HIV infection. HIV Med 5(2): 93-98.
12. Ostermann J, Kumar V, Pence BW, Whetten K (2007) Trends in HIV testing and differences between planned and actual testing in the United State, 2000-2005. Arch Intern Med 167(19): 2128-2135.
13. Fuente L, Suarez M, Belza MJ, Vallejo F, García M, et al. (2009) Human immunodeficiency virus testing uptake and risk behaviours in Spain. J Epidemiol Community Health 63: 552-558.
14. Signorelli C, Pasquarella C, Limina RM, Colzani E, Fanti M, et al. (2006) Third Italian national survey on knowledge attitudes, and sexual behaviour in relation to HIV/AIDS risk and the role of health education campaigns. Eur J Public Health 16: 498-504.
15. França-Junior I, Calazans G, Zucchi EM, Grupo de Estudos em População, Sexualidade e Aids (2008) Change in HIV Testing in Brazil between 1998 and 2005. Rev Saúde Pública 42(supl.1): 84-97.
16. Paltiel AD, Weinstein MC, Kimmel AD, Seagel GR, Losina E, et al. (2005) Expand Screening for HIV in the United States - an analysis of costeffectiveness. N Engl J Med 352: 586-595.
17. Obermeyer CM, Osborn M (2007) The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. Am J Public Heath 97: 1762-1774.
18. Deblonde J, Koker P, Hamers FF, Fontaine J, Lucthers S, et al. (2010) Barriers to HIV testing in European: a systematic review. Eur J Public Health 2010. (advance access fev, 2010). doi:10.1093/eurpub/ckp231.
19. Burns FM, Johnson AM, Nazroo J, Ainsworth J, Anderson J, et al. (2008) Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS 22: 115-122.
20. Delpierre C, Dray-Spira R, Cuzin L, Marchou B, Massip P, et al. (2007) Correlates of late HIV diagnosis: implications for testing policy. International Journal of STD & AIDS 18: 312-317.
21. Reed JB, Hanson D, McNaghten AD, Bertolli J, Teshale E, et al. (2009) HIV test factors associated with delayed entry into HIV medical care among HIVinfected persons from eighteen States, United States, 2000-2004. AIDS Patient Care and STDs 23(9): 765-773.
22. Carnicer-Pont D, Olalla PG, Cayla JA (2006) HIV infection late detection in AIDS patients of an European city with increased immigration since mid 1990s. Current HIV Research 7(2): 237-243.
23. Centers for Disease Control for Prevention (2009) Late HIV test. 34 states, 1996-2005. MMWR 58(24): 661-665.
24. The ART-LINC Collaboration of the International Databases to evaluate AIDS (IeDEA) (2008) Antiretroviral therapy in resource-limited setting 1996 to 2006: patients characteristic, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Tropical Medicine and International Health; 13(7): 870-879.
25. Thanawulth N, Chongsuvivatwong V (2008) Late HIV diagnosis and delay in CD4 count measurement among HIV-infected patients in southern Thailand. AIDS Care 20(1): 43-50.
26. Fernandes JRM, Acurcio FA, Campos LN, Guimarães MDC (2009) Initiation of antiretroviral therapy in HIV-infected patients with severe immunodeficiency in Belo Horizonte, Minas Gerais State, Brazil. Cad. Saúde Pública 25(6): 1369-80.
27. Souza-Jr PRB, Szwarcwald CL, Castilho EA (2007) Delay introducing antiretroviral therapy in patients infected by HIV in Brazil, 2003-2006. Clinics 62(5): 579-84.
28. World Health Organization (2009) Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. Geneva: World Health Organization. Available: http://www.who.int/hiv/pub/arv/rapid_advice_art.pdf. Accessed 2010 November 9.
29. Brazilian Ministry of Health, Health Surveillance Secretariat, National Programme STD and AIDS (2008) Targets and Commitments made by the Member-States at the United Nations General Assembly Special Session on HIV/AIDS (UNGASS - HIV/AIDS). Brazilian Response: 2005/2007. Country Progress Report. Brasília: National Programme STD and AIDS. Available: http://data.unaids.org/pub/report/2008/brazil_2008_country_progress_report_en.pdf. Accessed 2010 June 04.
30. Okie S (2006) Fighting HIV: lessons from Brazil. N Engl J Med 354(19): 1977-81.
31. Campos DP, Ribeiro SR, Grinsztejn B, Veloso V, Valente JG (2005) Survival of AIDS patients using two case definitions, Rio de Janeiro, Brazil, 1986-2003. AIDS 19(suppl): S22-S26.
32. Jorge MHPM, Laurenti R, Gotlieb SLD (2007) Quality analysis of Brazilian vital statistics: the experience of implementing the SIM and SINASC systems. Ciência & Saúde Coletiva 12(3): 643-654.
33. Lucena FFA, Fonseca MG, Sousa AIA, Coeli CM (2006) Appling record linkage in AIDS surveillance. Cadernos de Saúde Coletiva 14(2): 305-312.
34. Gonçaves VF, Kerr LRFS, Mota RMS, Mota JMA (2008) Estimation of underreporting of AIDS cases in a Brazilian Northeast metropolis. Rev Bras Epidemiol 11(3): 356-64.
35. Fonseca MG, Bastos FI (2007) Twenty-five years of the AIDS epidemic in Brazil: principal epidemiological findings, 1980-2005. Cad Saude Publica 23(Supl 3): S333-44.
36. Sighen V, Sven D, Azra G, Luuk G, Roy A (2005) Mortality in Patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individuals. J Acquir Immune Defic Syndr 40(2): 212-218.
37. Fonseca MP, Coeli CM, Lucena FA, Veloso VG, Carvalho MS (2010) Accuracy of a probabilistic record linkage strategy applied to identify deaths among cases reported to the Brazilian AIDS surveillance database. Cad Saúde Pública 26(7): 1431-38.
38. Kelsey JL, Whittemore AS, Evans AS, Thompson WD (1996) Methods in observational epidemiology. New York: Oxford University Press.
39. The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) groups (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817-824.
40. Braga P, Cardoso MA, Segurado AC (2007) Gender Differences in survival in a HIV/AIDS cohort from São Paulo, Brazil. AIDS Patient Care 21(5): 321-328.
41. Braga PE, Cardoso MRA, Segurado AC (2007) Gender differences among persons with HIV admitted to a university reference center in São Paulo, Brazil. Cad. Saúde Pública 23(11): 2653-62.
42. Ministério da Saúde do Brasil (2000) Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV - 2000. Brasília: Ministério da Saúde do Brasil. Available: http://www.aids.gov.br/sites/default/files/Consenso_ARV_Adulto_-_versao_2000.pdf. Accessed 2010 November 9.
43. Severe P, Juste MAJ, Ambroise A, Eliacin L, Marchand C (2010) Early versus standar antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 363: 257-65.
44. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2008) Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART Study. JID 197: 1133-44.
45. Siegfried N, Uthman OA, Rutherford GW (2010) Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.; Cochrane Databases of Systematic Reviews Issue 3 Art. No CD008272. doi: 10.1002/14651858.CD008272.pub2.
46. Grangeiro A, Escuder MM, Veras MA, Barreira D, Ferraz D, et al. (2009) Voluntary counseling and testing (VCT) services and their contribution to access to HIV diagnosis in Brazil. Cad Saúde Pública 25(9): 2053-63.
47. Lemos KRV, Valente JG (2001) Death certificates as a marker for underrecording of AIDS cases. Cad. Saúde Pública 17(3): 617-26.